HST
39
-3
DE
42
3
CAT
59
-2
NOV
52
-5
IPG
34
-9
UAL
83
-2
CINF
53
3
FMC
23
-3
LRCX
37
-9
ADSK
66
-4
TDC
67
-4
KLAC
38
-6
SYF
86
-6
HBI
58
3
TXT
53
-3
BSX
64
-3
KMX
61
-3
HSIC
45
5
GIS
22
-4
COF
62
3
HST
39
-3
DE
42
3
CAT
59
-2
NOV
52
-5
IPG
34
-9
UAL
83
-2
CINF
53
3
FMC
23
-3
LRCX
37
-9
ADSK
66
-4
TDC
67
-4
KLAC
38
-6
SYF
86
-6
HBI
58
3
TXT
53
-3
BSX
64
-3
KMX
61
-3
HSIC
45
5
GIS
22
-4
COF
62
3
Financhill
Back

NXG Cushing Midstream Energy Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
58

SRV
NXG Cushing Midstream Energy Fund

Last Price:
43.42
Seasonality Move:
-3.9%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
58
NXG Cushing Midstream Energy Fund (SRV) is a Buy

Is NXG Cushing Midstream Energy Fund a Buy, Sell or Hold?

  • The current NXG Cushing Midstream Energy Fund [SRV] share price is $43.47. The Score for SRV is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRV Stock Price Chart

What is NXG Cushing Midstream Energy Fund's stock price today?

  • The NXG Cushing Midstream Energy Fund share price today is $43.47
    The current trend is relatively stagnant and SRV is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SRV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 50.05 Buy
Chaikin Money Flow: 54907 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.45 - 46.03) Sell
Bollinger Bands (100): (41.44 - 44.92) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SRV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.33 Buy
20-day SMA: 43.08 Buy
50-day SMA: 44.12 Sell
200-day SMA: 41.78 Buy
8-day EMA: 43.14 Buy
20-day EMA: 43.29 Buy
50-day EMA: 43.6 Sell
200-day EMA: 41.82 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

NXG Cushing Midstream Energy Fund Earnings Growth & SRV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

NXG Cushing Midstream Energy Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):